Mathieu E, Ritchie H, Rodés-Guirao L, et al. Coronavirus Pandemic (COVID-19). Our World Data. Published online March 5, 2020, 2023. https://ourworldindata.org/coronavirus. Accessed June 18
Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603–15. https://doi.org/10.1056/NEJMoa2034577.
Walsh EE, Frenck RW, Falsey AR, et al. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. N Engl J Med. 2020;383(25):2439–50. https://doi.org/10.1056/NEJMoa2027906.
Remmel A. COVID vaccines and safety: what the research says. Nature. 2021;590(7847):538–40.
Rahman MM, Masum MHU, Wajed S, Talukder A. A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges. Virusdisease. Published online February 1, 2022:1–22. https://doi.org/10.1007/s13337-022-00755-1
Newburger E. FDA adds warning about rare heart inflammation to Pfizer, Moderna Covid vaccines. CNBC. Published June 26, 2021. https://www.cnbc.com/2021/06/26/fda-adds-warning-of-rare-heart-inflammation-to-pfizer-moderna-vaccines.html. Accessed July 16, 2023
Whittaker E, Bamford A, Kenny J, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324(3):259–69. https://doi.org/10.1001/jama.2020.10369.
Godfred-Cato S, Bryant B, Leung J, et al. COVID-19-associated multisystem inflammatory syndrome in children – United States, March-July 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1074–80. https://doi.org/10.15585/mmwr.mm6932e2.
Gupta A, Gill A, Sharma M, Garg M. Multi-system inflammatory syndrome in a child mimicking kawasaki disease. J Trop Pediatr. 2021;67(3):fmaa060. https://doi.org/10.1093/tropej/fmaa060.
Morris SB, Schwartz NG, Patel P, et al. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 Infection – United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(40):1450–6. https://doi.org/10.15585/mmwr.mm6940e1.
Vogel TP, Top KA, Karatzios C, et al. Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021;39(22):3037–49. https://doi.org/10.1016/j.vaccine.2021.01.054.
Payne AB, Gilani Z, Godfred-Cato S, et al. Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2. JAMA Netw Open. 2021;4(6):e2116420–e2116420. https://doi.org/10.1001/jamanetworkopen.2021.16420.
La Torre F, Elicio MP, Monno VA, et al. Incidence and Prevalence of Multisystem Inflammatory Syndrome in Children (MIS-C) in Southern Italy. Children. 2023;10(5). https://doi.org/10.3390/children10050766
Belay ED, Godfred Cato S, Rao AK, et al. Multisystem Inflammatory Syndrome in Adults After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Coronavirus Disease 2019 (COVID-19) Vaccination. Clin Infect Dis Off Publ Infect Dis Soc Am. Published online November 28, 2021:ciab936. https://doi.org/10.1093/cid/ciab936
Nune A, Iyengar KP, Goddard C, Ahmed AE. Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V). BMJ Case Rep. 2021;14(7). https://doi.org/10.1136/bcr-2021-243888
JBI Critical Appraisal Tools | JBI. https://jbi.global/critical-appraisal-tools. Accessed July 16, 2023
Joshi S, Bhatia A, Tayal N, Jha LK, Gupta P. Rare Multisystem Inflammatory Syndrome in Young Adult after COVID-19 Immunization and Subsequent SARSCoV-2 Infection. J Assoc Physicians India. 2022;69(12):11–2.
Yalçinkaya R, Öz FN, Polat M, et al. A Case of Multisystem Inflammatory Syndrome in a 12-Year-old Male After COVID-19 mRNA Vaccine. Pediatr Infect Dis J. 2022;41(3):e87–9. https://doi.org/10.1097/INF.0000000000003432.
DeJong J, Sainato R, Forouhar M, Robinson D, Kunz A. multisystem inflammatory syndrome in a previously vaccinated adolescent female with sickle cell disease. Pediatr Infect Dis J. 2022;41(3):e104–5. https://doi.org/10.1097/INF.0000000000003444.
Abdelgalil AA, Saeedi FA. Multisystem Inflammatory Syndrome in a 12-Year-old Boy After mRNA-SARS-CoV-2 Vaccination. Pediatr Infect Dis J. 2022;41(3):e93–4. https://doi.org/10.1097/INF.0000000000003442.
Hugh McGann P, Krim AOA, Green J, Venturas J. Multi inflammatory syndrome in a 16-year-old male following first dose of m-RNA COVID-19 vaccination. Clin Infect Pract. 2022;14:100139. https://doi.org/10.1016/j.clinpr.2022.100139.
Miyazato Y, Yamamoto K, Yamada G, et al. Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine. Emerg Infect Dis. 2022;28(4):870–2. https://doi.org/10.3201/eid2804.212585.
Choi YK, Moon JY, Kim J, et al. Postvaccination multisystem inflammatory syndrome in adult with no evidence of prior SARS-CoV-2 infection. Emerg Infect Dis. 2022;28(2):411–4. https://doi.org/10.3201/eid2802.211938.
Bova C, Vigna E, Gentile M. Multisystem Inflammatory Syndrome after Ad26.COV2.S vaccination. IDCases. 2022;27:e01411. https://doi.org/10.1016/j.idcr.2022.e01411.
Chai Q, Nygaard U, Schmidt RC, Zaremba T, Møller AM, Thorvig CM. Multisystem inflammatory syndrome in a male adolescent after his second Pfizer-BioNTech COVID-19 vaccine. Acta Paediatr Oslo Nor 1992. 2022;111(1):125–7. https://doi.org/10.1111/apa.16141.
Poussaint TY, LaRovere KL, Newburger JW, et al. Multisystem inflammatory-like syndrome in a child following COVID-19 mRNA vaccination. Vaccines. 2021;10(1):43. https://doi.org/10.3390/vaccines10010043.
Lee S, Ardoin SP, Blaney C, et al. Multisystem inflammatory syndrome in children after breakthrough infection in a COVID-19-vaccinated child. Pediatr Infect Dis J. 2022;41(4):e182–3. https://doi.org/10.1097/INF.0000000000003451.
Al Bishawi A, Ali M, Al-Zubaidi K, Abdelhadi H. Beware of the ambiguous enemy of multisystem inflammatory syndrome in adult (MIS-A) following Covid-19 infection or vaccination. Clin Case Rep. 2021;9(11):e05138. https://doi.org/10.1002/ccr3.5138.
Park JW, Yu SN, Chang SH, Ahn YH, Jeon MH. Multisystem inflammatory syndrome in an adult after COVID-19 vaccination: a case report and literature review. J Korean Med Sci. 2021;36(45):e312. https://doi.org/10.3346/jkms.2021.36.e312.
Buchhorn R, Meyer C, Schulze-Forster K, Junker J, Heidecke H. Autoantibody release in children after corona virus mRNA vaccination: a risk factor of multisystem inflammatory syndrome? Vaccines. 2021;9(11):1353. https://doi.org/10.3390/vaccines9111353.
Uwaydah AK, Hassan NMM, Ghoush MSA, Shahin KMM. Adult multisystem inflammatory syndrome in a patient who recovered from COVID-19 postvaccination. BMJ Case Rep CP. 2021;14(4):e242060. https://doi.org/10.1136/bcr-2021-242060.
Agarwal AK, Lamba B, Kumari V, Kaushik A, Chaudhary A, Gadpayle AK. Covid-19-related multisystem inflammatory syndrome in adults: An uncommon case. J Indian Acad Clin Med. 2021;22(3-4):147–50.
Bangash B, Pitcher J, Makki I. Multisystem inflammatory syndrome in children and adolescents (MIS-C) in a young adult with recent vaccination. Chest. 2021;160(4):A660. https://doi.org/10.1016/j.chest.2021.07.627.
Deb A, Abdelmalek J, Iwuji K, Nugent K. Acute myocardial injury following COVID-19 vaccination: a case report and review of current evidence from vaccine adverse events reporting system database. J Prim Care Community Health. 2021;12:21501327211029230. https://doi.org/10.1177/21501327211029230.
Salzman MB, Huang CW, O’Brien CM, Castillo RD. Multisystem inflammatory syndrome after SARS-CoV-2 infection and COVID-19 vaccination. Emerg Infect Dis. 2021;27(7):1944–8. https://doi.org/10.3201/eid2707.210594.
Koga T, Yoshimura M, Kubo S, et al. Multisystem Inflammatory Syndrome after COVID-19 Vaccination (MIS-V) Presenting with Retropharyngeal Phlegmon in a 15-year-old Boy in Japan. Am J Med Case Rep. 2022;10(2):35–8. https://doi.org/10.12691/ajmcr-10-2-4.
Lieu A, Mah J, Church D. A case of multisystem inflammatory syndrome in adults following natural infection and subsequent immunization. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2022;116:34–7. https://doi.org/10.1016/j.ijid.2021.12.339.
Baicus C, Delcea C, Pinte L, Dan GA. Hyper-inflammation after COVID-19 mARN vaccination: at the crossroads of multisystem inflammatory disease and adult-onset Still’s disease. Does terminology matter? Romanian J Intern Med Rev Roum Med Interne. 2022;60(1):3–5. https://doi.org/10.2478/rjim-2021-0035.
Kahn B, Apostolidis SA, Bhatt V, et al. Multisystem Inflammation and Organ Dysfunction After BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccination. Crit Care Explor. 2021;3(11):e0578.:https://doi.org/10.1097/CCE.0000000000000578
Taneja V, Khosla P. Post vaccination -Multisystemic inflammatory syndrome -adults. Ann Clin Med Case Rep. 2021;7(5):1–2.
Grome HN, Threlkeld M, Threlkeld S, et al. Fatal Multisystem Inflammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 Vaccination. Emerg Infect Dis. 2021;27(11):2914–8. https://doi.org/10.3201/eid2711.211612.
Ouldali N, Bagheri H, Salvo F, et al. Multisystemic inflammatory syndrome following COVID-19 mRNA vaccine in children: a national post-authorization pharmacovigilance study. Published online January 18, 2022:2022.01.17.22269263. https://doi.org/10.1101/2022.01.17.22269263
Levy M, Recher M, Hubert H, et al. Multisystem inflammatory syndrome in children by COVID-19 vaccination Status of Adolescents in France. JAMA. 2022;327(3):281–3. https://doi.org/10.1001/jama.2021.23262.
Jain E, Donowitz JR, Aarons E, Marshall BC, Miller MP. Multisystem Inflammatory Syndrome in Children after SARS-CoV-2 Vaccination. Emerg Infect Dis. 2022;28(5):990–3. https://doi.org/10.3201/eid2805.212418.
Yao Q, Waley L, Liou N. Adult presentation of multisystem inflammatory syndrome (MIS) associated with recent COVID-19 infection: lessons learnt in timely diagnosis and management. BMJ Case Rep. 2021;14(10):e243114. https://doi.org/10.1136/bcr-2021-243114.
Patel T, Kelleman M, West Z, et al. Comparison of multisystem inflammatory syndrome in children-related myocarditis, classic viral myocarditis, and COVID-19 vaccine-related myocarditis in children. J Am Heart Assoc. 2022;11(9):e024393. https://doi.org/10.1161/JAHA.121.024393.
Chin SE, Bhavsar SM, Corson A, Ghersin ZJ, Kim HS. Cardiac complications associated with COVID-19, MIS-C, and mRNA COVID-19 Vaccination. Pediatr Cardiol. 2022;43(3):483–8. https://doi.org/10.1007/s00246-022-02851-x.
Rhedin S, Lundholm C, Horne A, et al. Risk factors for multisystem inflammatory syndrome in children – A population-based cohort study of over 2 million children. Lancet Reg Health Eur. 2022;19:100443. https://doi.org/10.1016/j.lanepe.2022.100443.
Zambrano LD, Newhams MM, Olson SM, et al. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years – United States, July-December 2021. MMWR Morb Mortal Wkly Rep. 2022;71(2):52–8. https://doi.org/10.15585/mmwr.mm7102e1.
Long F, Zhu S, Wang Z, et al. Update on the treatment of multisystem inflammatory syndrome in children associated with COVID-19. Future Virol. 2023;18(1):63–74. https://doi.org/10.2217/fvl-2022-0048.
Mahmoud S, El-Kalliny M, Kotby A, El-Ganzoury M, Fouda E, Ibrahim H. Treatment of MIS-C in Children and Adolescents. Curr Pediatr Rep. 2022;10(1):1–10. https://doi.org/10.1007/s40124-021-00259-4.
Algarni AS, Alamri NM, Khayat NZ, Alabdali RA, Alsubhi RS, Alghamdi SH. Clinical practice guidelines in multisystem inflammatory syndrome (MIS-C) related to COVID-19: a critical review and recommendations. World J Pediatr WJP. 2022;18(2):83–90. https://doi.org/10.1007/s12519-021-00499-w.
Multisystem Inflammatory Syndrome in Children (MIS-C) Interim Guidance. https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/multisystem-inflammatory-syndrome-in-children-mis-c-interim-guidance/. Accessed July 10, 2023